Latest Strategic Partnership News

ABx Group’s subsidiary ABx3 has received a $2.7 million investment from Good Importing International, granting GII 70% ownership to develop the Sunrise Bauxite Project in Queensland. This funding kickstarts a 12–24 month program targeting regulatory approvals and mine planning, with further investment options on the horizon.

Ainsworth Game Technology’s CEO Harald Neumann faces a setback as the Nevada Gaming Control Board recommends withdrawing his license application, prompting a board review of his role.

Kinetiko Energy hosts senior South African government dignitaries at its Brakfontein gas project, highlighting record gas flows and plans for a pilot LNG plant to address the country’s energy crisis.

Liontown Resources has secured a one-year deferral on debt repayments to Ford and halved its spodumene concentrate commitments, unlocking new sales opportunities amid evolving lithium markets.

EV Resources reports strong metallurgical results from its Los Lirios Antimony Project, confirming high antimony grades alongside gold and silver by-products, paving the way for fast-track production and strategic alignment with U.S. critical minerals supply chains.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

Brazilian Rare Earths has secured a decade-long heavy rare earth offtake deal with Carester, aligning Brazil’s high-grade resources with a leading European separation facility. This partnership also includes engineering support to accelerate BRE’s refinery development.

Netwealth Group Limited has reported a landmark quarter with total Funds Under Administration soaring to $120.8 billion, driven by record first-quarter net flows of $4.1 billion and strategic service expansions.

Hastings Technology Metals has responded to an ASX price query, denying any undisclosed information behind its recent share price and volume spike, citing recent joint venture and asset sale announcements as likely drivers.

NH3 Clean Energy updates investors on the WAH2 clean ammonia project, highlighting strong market potential, strategic partnerships, and robust project economics as it moves toward a Final Investment Decision.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Anatara Lifesciences has completed the first tranche of its two-part share placement, issuing over 33 million ordinary shares to professional investors. This move marks a significant step in the company’s capital raising efforts amid ongoing product development.